Carlsmed, Inc. to Report Third Quarter 2026 Financial Results on November 10, 2026
Carlsmed (CARL) will report its third quarter 2026 financial results after market close on November 10, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Carlsmed (CARL) will report its third quarter 2026 financial results after market close on November 10, 2026.
Management will host a conference call and concurrent webcast at 1:30 PM Pacific Time. The live webcast will be available on the company’s investor website, with a replay archived after the call.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CARLSBAD, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its third quarter 2026 financial results after market close on Tuesday, November 10, 2026. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time.
A live webcast of the conference call will be available in the Events & Presentations section of the Company’s investor website at investors.carlsmed.com. Participants may also join via telephone by registering here. A replay will be archived on the Company’s website following completion of the call.
About Carlsmed
Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.
Investor Relations
IR@Carlsmed.com
